Showing results (851-860 of 1,047) with videos related to
Sort By:
Pageof 105
International Journal of Radiation Oncology, Biology, Physics|March 7, 2025
Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan TrialAndreas Rimner, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.Frontiers in Oncology|March 20, 2026
Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer after prior vascular endothelial growth factor receptor-targeted therapy (COSMIC-311): outcomes by BRAF statusMarcia S Brose, Bhumsuk Keam, Jolanta Krajewska, et al.Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growthHung-En Hsia, Rohit Kumar, Rossella Luca, et al.The Lancet. Oncology|March 30, 2019
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trialVicky Makker, Drew Rasco, Nicholas J Vogelzang, et al.Biorxiv : the Preprint Server for Biology|September 10, 2024
PD-linked LRRK2 G2019S mutation impairs astrocyte morphology and synapse maintenance via ERM hyperphosphorylationShiyi Wang, Ryan Baumert, Gabrielle Séjourné, et al.Journal for Immunotherapy of Cancer|January 19, 2024
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146Vicky Makker, Matthew H Taylor, Carol Aghajanian, et al.Molecular Biology of the Cell|April 29, 2017
A novel Munc13-4/S100A10/annexin A2 complex promotes Weibel-Palade body exocytosis in endothelial cellsTarek Chehab, Nina Criado Santos, Anna Holthenrich, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOGErik F Moar, Michael Keilholz, Gabriel T Sheikh, et al.BMC Cancer|June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibJames C H Yang, Marcia S Brose, Gilberto Castro, et al.Cancer Research|July 5, 2006
Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomasStephan Woditschka, Jill D Haag, Jordy L Waller, et al.Pageof 105